Pseudomonas aeruginosa vesicles associate with and are internalized by human lung epithelial cells
© Bauman and Kuehn; licensee BioMed Central Ltd. 2009
Received: 08 July 2008
Accepted: 03 February 2009
Published: 03 February 2009
Pseudomonas aeruginosa is the major pathogen associated with chronic and ultimately fatal lung infections in patients with cystic fibrosis (CF). To investigate how P. aeruginosa-derived vesicles may contribute to lung disease, we explored their ability to associate with human lung cells.
Purified vesicles associated with lung cells and were internalized in a time- and dose-dependent manner. Vesicles from a CF isolate exhibited a 3- to 4-fold greater association with lung cells than vesicles from the lab strain PAO1. Vesicle internalization was temperature-dependent and was inhibited by hypertonic sucrose and cyclodextrins. Surface-bound vesicles rarely colocalized with clathrin. Internalized vesicles colocalized with the endoplasmic reticulum (ER) marker, TRAPα, as well as with ER-localized pools of cholera toxin and transferrin. CF isolates of P. aeruginosa abundantly secrete PaAP (PA2939), an aminopeptidase that associates with the surface of vesicles. Vesicles from a PaAP knockout strain exhibited a 40% decrease in cell association. Likewise, vesicles from PAO1 overexpressing PaAP displayed a significant increase in cell association.
These data reveal that PaAP promotes the association of vesicles with lung cells. Taken together, these results suggest that P. aeruginosa vesicles can interact with and be internalized by lung epithelial cells and contribute to the inflammatory response during infection.
Pseudomonas aeruginosa is the major pathogen associated with chronic and ultimately fatal lung infections in patients with cystic fibrosis (CF). Current research suggests that P. aeruginosa live anaerobically in the mucus layer of the CF lung and are rarely found in contact with epithelial cells [1, 2]. Extracellular proteases are secreted by P. aeruginosa, including Las A, elastase, alkaline protease, and protease IV, and these are known contributors to virulence in lung infections [3–5]. Like other gram negative bacteria, P. aeruginosa also release spheres of outer membrane known as outer membrane vesicles . They consist of entrapped periplasmic components and outer membrane constituents, including lipopolysaccharide (LPS), glycerophospholipids, and outer membrane proteins (OMPs) . Due to their small size, vesicles potentially gain access to host cells more easily than whole bacteria. Considering that vesicles are armed with bacterial proteases, toxins, surface adhesins and/or invasins, vesicles present a potentially significant contributor to lung damage caused by P. aeruginosa. Since they contain many immunostimulatory compounds, it is not surprising that P. aeruginosa vesicles induce a significant IL-8 response from cultured human lung cells .
Vesicles allow bacteria to disperse a complex of soluble and insoluble bacterial products into the surrounding milieu. Vesiculation appears to be a conserved process among both pathogenic and non-pathogenic bacteria and the role of outer membrane vesicles in pathogenesis is a burgeoning area of research . Many pathogenic bacterial species aside from P. aeruginosa produce vesicles that contain toxins or other virulence factors and, in several cases, vesicles have been proposed to be vehicles for toxin delivery to eukaryotic cells [10–16]. In order to deliver toxic content, vesicles must first bind to host cells. Vesicles from Shigella flexneri , Borellia burgdorferi , Actinobacillus actinomycetemcomitans [13, 19] and ETEC [14, 20] have been observed to bind cultured host cells. Vesicles have also been observed interacting with host cells in vivo. In biopsies of infected patients, vesicles from H. pylori were found to bind intestinal cells [10, 21].
P. aeruginosa vesicles have been amongst the most thoroughly studied vesicles to date. They have been shown to contain the virulence factors pro-elastase, hemolysin, phospholipase C, and alkaline phosphatase, as well as the penicillin-degrading enzyme β-lactamase and the Pseudomonas quorum sensing signal (PQS) and other hydroxyalkylquinolones [22–24]. We recently reported that the secreted aminopeptidase, PaAP, is enriched in outer membrane vesicles that we purified from each of the tested CF strains of P. aeruginosa . Interestingly, PaAP expression was found to increase 21-fold when PAO1 was grown under microaerobic conditions , and 103-fold when it was grown in the presence of primary lung epithelial cells . An analogous zinc metalloprotease was discovered to be associated with vesicles produced by a different CF pathogen, Burkholderia cepacia, and a strain with a knockout in this gene was less virulent in an animal model . Such studies have stimulated much interest in determining how vesicles and vesicle components contribute to P. aeruginosa infection and disease in the lungs.
In this study, we use both cultured and primary airway epithelial cells to investigate vesicle-host cell interactions and to assess the contribution of PaAP to this interaction. We report that P. aeruginosa vesicles are internalized by human lung cells and PaAP increases vesicle association with lung cells. The results point to physiological roles for P. aeruginosa PaAP and vesicles during an infection.
P. aeruginosavesicle association with lung epithelial cells is strain-dependent
To test whether the vesicles would interact similarly with primary cells, we incubated vesicles with human bronchial epithelial (HBE) cells from healthy human volunteers (Fig. 1B). The results for the HBE cells were similar to those with cultured cells, thus cultured cells appeared to be a good model for primary cells in further assays. Together, these data indicate that P. aeruginosa vesicles from CF strains associate to a greater extent with epithelial cells than vesicles from a non-CF strain.
Pseudomonas aeruginosavesicles are trafficked into lung epithelial cells
Temperature-dependent association of S470 vesicles suggested that these vesicles may be internalized by the lung epithelial cells. We used confocal microscopy to analyze vesicle-host cell interactions. Cultured A549 cells were incubated with FITC-labeled S470 vesicles for 6 hours at 37°C, and plasma membranes were stained with AF633-wheat germ agglutinin (WGA) to visualize cell boundaries. At 37°C, vesicle fluorescence appeared to be mostly internal and concentrated in a perinuclear region of the cell (Fig. 2B). Very little vesicle association was observed for incubations maintained at 4°C (Fig. 2C). Thus, both binding and internal localization of S470 vesicles was affected at the lower temperature.
To investigate the mode of P. aeruginosa vesicle internalization, we treated cells with common inhibitors of endocytic pathways. Filipin, chlorpromazine, cytochalasin D, and NiCl2 did not inhibit uptake (data not shown). Pre-treatment of cells with methyl-β-cyclodextrin (MβCD), which removes cholesterol from membranes, inhibited vesicle uptake, however, preincubation with methyl-α-cyclodextrin, which typically is used as a negative control for MβCD, inhibited vesicle uptake as well (Fig. 3C and 3D). Inhibition of vesicle uptake was also achieved using hypertonic sucrose (Fig 3E). In parallel control incubations, we pretreated vesicles with hypertonic sucrose or cyclodextrins instead of pretreating the lung cells. In these controls, vesicles were still readily internalized (data not shown), indicating that the inhibition of vesicle uptake was due to effects on the lung cells and not on the vesicles themselves.
Internalized vesicle components colocalize with the endoplasmic reticulum
PaAP promotes vesicle association with human respiratory epithelial cells
With these results, we have revealed several facets of interactions between P. aeruginosa vesicles and human lung epithelial cells. We have demonstrated that P. aeruginosa vesicles are internalized by epithelial cells and trafficked intracellularly so that vesicle components accumulate in the ER. We have also shown that PaAP, an enzyme more abundant in vesicles produced by many CF isolates compared with non-clinical isolates, significantly contributes to the interaction of P. aeruginosa vesicles with host cells.
Internalization by host cells has been reported to occur for outer membrane vesicles from numerous species. For instance, our lab has shown previously that ETEC vesicles are internalized in an LT-dependent fashion via ganglioside GM1 in caveolin-enriched lipid rafts of epithelial cells . Additionally, fluorescent beads coated with Porphyromonas gingivalis vesicles also colocalized with caveolin and GM1 and were internalized by HeLa cells in a cholesterol and dynamin-dependent manner . Our observations regarding the temperature-dependent extent and location of vesicle-associated fluorescence in host cells and decreased fluorescence in host cells upon pretreatment with methyl-β-cyclodextrin (which disrupts caveolae, lipid rafts, as well as clathrin-coated pit-mediated entry pathways) suggested that S470 vesicles were also internalized.
In contrast to other examples of internalized vesicles, P aeruginosa vesicles appear to enter host cells via multiple pathways. Hypertonic media, which impairs clathrin coated pit formation, did significantly decrease vesicle internalization and some surface-bound vesicles were found colocalized with clathrin. However, neither treatment with filipin, which disrupts lipid rafts, nor chlorpromazine, which blocks clathrin-coated pits, decreased vesicle internalization significantly. It should also be considered that P. aeruginosa vesicles could fuse with the epithelial cells and that vesicle membrane components are subsequently internalized by plasma membrane trafficking while lumenal components are liberated into the host cell cytosol. Evidence of fusion of vesicles with the plasma membrane has been presented for Actinobacillus actinomycetemcomitans vesicles : Confocal microscopy of HL60 cells coincubated with these vesicles showed immediate and strong labelling, primarily at the plasma membrane. We did not observe strong perimeter labelling of host cells with P. aeruginosa vesicles (Fig 2B). In fact, when we blocked active transport with hypertonic sucrose, we found a significant decrease in vesicle-associated fluorescence, not accumulation of fluorescence at the cell periphery (Fig 3E). Thus, our data support a model where P. aeruginosa vesicles do not fuse to the plasma membrane, but instead bind and are internalized.
We observed an increase in human lung epithelial cell-associated fluorescence over time. This result is consistent with either vesicle attachment causing receptor upregulation, or continuous vesicle binding, internalization, recycling of vesicle receptors to the cell surface. These characteristics are similar to the behavior of enterotoxigenic E. coli vesicles with intestinal epithelial cells . Further experiments using different inhibitors, markers, and cell lines, will be necessary to definitively identify the host cell factors critical to P. aeruginosa vesicle entry. In relation to CF-related research, it would be particularly interesting to see whether the interactions depend on functional and properly localized CFTR. Ceramide-rich rafts containing clusters of the CFTR and CD95 have been implicated as the means for internalization of whole P. aeruginosa. These rafts are disrupted by MβCD, and thus in light of our MβCD treatment results, they present a potential route for vesicle internalization .
Once internalized, vesicles may be sequestered, degraded, or their components may be dispersed, with their membranes disrupted and/or fused with the endocytic membrane. In the case of S. flexneri vesicles, for instance, vesicle lumenal content was found in the host cell cytosol after vesicles were phagocytosed to a non-acidified compartment by Henle 407 epithelial cells . We show that P. aeruginosa vesicle-associated intracellular fluorescence is concentrated to bright puncta and do not encounter an acidified compartment, since vesicle-associated FITC fluorescence (which is pH sensitive) is not quenched, even in long incubations (Fig 1). Notably, a significant amount of vesicle-associated fluorescence colocalized with the integral ER membrane protein TRAPα, even after a relatively brief incubation time. Transferrin and CT eventually route to the ER, and indeed, those pools of Transferrin and CT that had reached the ER colocalized with the vesicle fluorescence. None of the currently identified P. aeruginosa vesicle proteins have an ER retention sequence to direct the trafficking of these bacterial factors to the ER (such as the case for LT which has RDEL at its C-terminus). Since intracellular trafficking of S470APKO5 vesicles was not noticeably different from S470 vesicles (data not shown), internalized vesicle trafficking appears to be PaAP-independent. In all, many questions remain regarding the trafficking of P. aeruginosa vesicle membrane and lumenal content after endocytosis, and this area deserves further exploration.
In some cases the factor on bacterial vesicles responsible for host cell binding has been identified as a virulence factor . For example, the heat-labile enterotoxin (LT) is bound to the surface of ETEC vesicles, and vesicle-bound LT mediates vesicle binding to cultured eukaryotic cells via the LT receptor, ganglioside GM1 [11, 14]. In contrast, leukotoxin transported in A. actinomycetemcomitans vesicles was not responsible for vesicle association with HL60 cells . We have found that PaAP also is located on the vesicle surface (preliminary data), and that host cell association correlated with PaAP levels on the vesicles. Strains overexpressing PaAP or deleted in PaAP, respectively, produced vesicles that associated to a greater or lesser extent than vesicles from the corresponding isogenic parent strains. A direct correlation between vesicle association and PaAP levels also held for strains naturally expressing PaAP at different levels. PaAP expression is highly regulated and typically does not occur until stationary phase [37–40]. This was true for our cultures of PAO1, and as a result PaAP was nearly absent from PAO1 vesicles purified from late log-phase cultures (see Fig 6 and [Additional file 2, Part A]). In contrast, strain S470 begins to express PaAP in late log phase, therefore PaAP was enriched in the late log-phase S470 vesicles (see Fig 6 and [Additional file 2, Part A]). Correspondingly, PAO1 vesicles associated 3–4 fold less than S470 vesicles (Fig 1). Thus, the degree of bacterial vesicle-host cell interaction can depend on the growth phase of the parent bacterium. Despite the importance of PaAP, it is not the only factor governing host cell association since association by S470APKO5 vesicles was only reduced by 40% compared with S470 vesicles. The conclusion that P. aeruginosa vesicles can utilize numerous internalization pathways is consistent with our finding that factors other than PaAP are involved in vesicle-host cell association.
We describe that PaAP expression in trans failed to complement the PaAP deletion with regards to the ability to obtain WT levels of vesicle-localized PaAP, and hence its ability to restore WT levels of vesicle association with host cells. Complemented PaAP was expressed and secreted into the culture supernatant at WT levels, however it was not found in the vesicle-associated fraction [see Additional file 3]. In fact, overexpression of PaAP in the null mutant resulted in reduced viability (unpublished data). This lack of functional complementation is not unprecedented. Two other secreted P. aeruginosa proteases (LasA and protease IV) have knockout phenotypes which could not be complemented by expression of the gene from a plasmid or even from a chromosomal insertion [41–43]. The lack of complementation by the plasmid-expressed PaAP in the APKO5 PaAP knockout strain demonstrates the likelihood of a fine-tuned regulatory process that is critical for optimal PaAP expression, processing, stability, and/or secretion. Indeed, PaAP has been found to undergo complex post-translational processing ((D. FitzGerald, personal communication, and ).
Since vesicle-associated PaAP has activity as a zinc-dependent protease, PaAP could act as a proteolytic factor that exposes vesicle receptors on the host cell surface. In an attempt to test this, we constructed a mutant PaAP which lacked active site residues however it was not secreted (preliminary data). Interestingly, this suggests PaAP must bind zinc for it to fold correctly and folding is critical for export of Type 2 secretory pathway substrates. As a result, we have not yet been able to test whether PaAP activity is important in mediating host cell interactions, internalization, or trafficking.
Purified P. aeruginosa vesicles associate with human lung cells and are internalized in a time- and dose-dependent manner. Vesicles from a CF isolate exhibit greater association with lung cells than vesicles from a lab strain. Vesicle internalization is temperature-dependent and inhibited by hypertonic sucrose and cyclodextrins. Vesicles also appear to be very transiently associated with clathrin-coated pits as part of an active uptake process. After internalization, vesicle components were found to colocalize with the ER. Tested CF isolates of P. aeruginosa abundantly secrete PaAP, an aminopeptidase which is a major contributor to lung cell association. Therefore, our results suggest that P. aeruginosa vesicles can interact with and be internalized by lung epithelial cells and thereby contribute to the inflammatory response during infection.
Bacterial strains and reagents
P. aeruginosa strains used were the laboratory strain PA01 (Pf1 phage-cured from our lab collection), the soil isolate ATCC 14886 (American Type Culture Collection, isolated prior to 1958), and minimally passaged, non-mucoid cystic fibrosis clinical isolates CF2, CF3, CF4, and S470 (Duke University Hospital). A549 human lung epithelia carcinoma cells were grown according to ATCC specifications in Kaighn's F-12K media containing 10% fetal bovine serum plus penicillin/streptomycin/fungizone. Human bronchial epithelial (HBE) cells were derived from anonymous healthy human volunteers. HBE cells were maintained in Bronchial Epithelial Cell Growth Media supplemented with thyroid extract. Unless indicated, all reagents were purchased from VWR.
Construction of PA01 overexpressing PaAP (PA01/pS41)
Primers used in these study (5' to 3' sequence)
KO up forward
KO up reverse
KO down forward
KO down reverse
Tet R cassette from pACYC184
EcoRI Tet forward
EcoRI Tet reverse
Xho Tet forward
Xho Tet reverse
Construction of PA2939 knockout in S470 (strain APKO5)
The PA2939 knockout vector (pAPKO) was constructed by interrupting the PA2939 sequence with a Tet cassette. DNA sequence starting from approximately 500 bp upstream of the PA2939 start codon to 30 bp into PA2939 was amplified by PCR using the "up" primers given in Table 1, which added a SpeI site to the 5' end of the DNA and mutated the 3' end to contain an EcoRI site. The remainder of the PA2939 sequence was amplified with the "down" primers given in Table 1, which mutated the 5' end to contain an EcoRI site and added an XhoI site to 3' end. The Tet cassette was amplified from plasmid pACYC184 using primers given in Table 1 that added EcoRI sites to both ends. The three pieces were combined sequentially using the pDrive subcloning vector (Qiagen). The final construct was cut out of pDrive using SpeI and XhoI sites and inserted into the MCS of pJQ200SK (GmR, SacB) to make plasmid pAPKO.
Triparental mating was used to introduce pAPKO into strain S470 using HB101/pAPKO as the donor strain, and MT616 as the helper strain. Successful conjugants were first selected on 1/2 PIA Tet (200 μg/ml) and Gm (20 μg/ml). Bacterial colonies that had undergone homologous recombination with the DNA containing the interruption of PA2939 were then counter-selected for resistance to Tet and sensitivity 5% sucrose and Gm. Knockout S470APKO5 was verified by PCR amplification of the interrupted PA2939 sequence, sequencing of the interrupted gene, and immunoblotting with anti-PaAP.
S470APKO5 was complemented with vector pS41 or empty vector pMMB66EH by triparental mating, as described above. Complementation was verified by PCR, restriction digests of plasmid DNA, and aminopeptidase detection by immunoblot and activity.
Vesicle isolation and purification
Vesicles were purified from a method adapted from Horstman and Kuehn . Bacteria were grown in LB broth overnight to early stationary phase. Cells were removed by pelleting (10,000 × g, 10 min). Supernatants were concentrated via a 100-kDa tangential filtration concentration unit (Pall-Gellman) to approximately 1/25th their original volume. The retentate was collected and centrifuged (6000 × g, 10 min) and then filtered through a 0.45 μm Durapore PVDF filter (Millipore) to remove remaining bacterial cells. Vesicles were obtained from the cell-free supernatant by one of two methods. In the first method, the vesicles were pelleted (39,000 × g, 1 h), resuspended in 50 mM HEPES, pH 6.8 (HEPES), and adjusted to 45% Optiprep (Greiner) in 10 mM HEPES/0.85% NaCl, pH 7.4 (HEPES-NaCl) (weight/weight). In the second method, the vesicles were precipitated with 71–75% ammonium sulfate (4°C, for at least 3 h), pelleted (10,000 × g, 20 min), dialyzed overnight with HEPES, concentrated (50 kDa MWCO Centriplus, Millipore), and adjusted to 45% Optiprep/HEPES-NaCl. Optiprep gradients were layered over the 2 ml crude vesicle samples as follows: For PAO1: 2 ml 40%, 2 ml 35%, 3 ml 30%, 2 ml 25%, 1 ml 20%; for Soil: 2 ml 40%, 2 ml 35%, 2 ml 30%, 2 ml 25%, 2 ml 20%; for CF isolates: 2 ml 40%, 2 ml 35%, 4 ml 30%, 2 ml 20% Optiprep/HEPES-NaCl by weight. Gradients were centrifuged (100,000 × g, 16 h) and 1 ml fractions removed from the top. A portion of each fraction was visualized by 15% SDS-PAGE. Pure vesicles were recovered from pooled peak fractions by dialyzing overnight against HEPES and pelleting (150,000 × g, 1 h). Vesicles were checked for sterility by culturing 5–50 μL on LB agar overnight at 37°C. Contaminated vesicles were filtered through 0.45 μm Microcon spin filters (Millipore) and recultured on LB plates.
Fluorescent labeling of vesicles
Purified vesicles were fluorescently labeled by incubating with fluorescein isothiocyanate (FITC) reagent (Sigma)(1 μg FITC/μg vesicle protein in 100 mM NaCl/50 mM Na2CO3, pH 9.2), for 2 h at 25°C with mixing, or with AlexaFluor-488 succinimidyl ester (AF488, Invitrogen, in 0.1 M Na2CO3, pH 9) according to manufacturer's instructions, for 1 h at 25°C with mixing. Free FITC and AF488 were removed from labeled vesicles by washing three times in HEPES (150,000 × g, 30 min). Labeled vesicles were checked for sterility and filtered through 0.45 μm PVDF spin filters when necessary.
Vesicle association assays
FITC-labeled vesicles (2.5 μg per well) were incubated with confluent monolayers (approx. 5 × 104 cells per well) of A549 human lung epithelia or HBE cells in serum-free media in 96-well plates (Costar) for 15 min to 24 h at 37°C or 4°C. All incubation conditions were done in triplicate. Cells were washed twice with PBS and then solubilized in 100 μ1 1% Triton X-100 in PBS. Fluorescence was quantitated using a FLUOstar Galaxy or FLUOstar Optima fluorometer (BMG Labtechnologies). A standard curve to correlate fluorescence measured in test wells to ng of vesicles was generated by adding purified FITC-labeled vesicles (0.5 ng–250 ng) from each strain to cells and immediately solubilizing the cells. Statistics were calculated using single-factor ANOVA.
All fluorescence microscopy reagents were purchased from Molecular Probes/Invitrogen unless otherwise stated. A549 human lung epithelia (1 × 105 cells per well) were seeded in LabTekII 8-well glass chamber slides (VWR) and incubated with fluorescently labeled vesicles (2.5 μg per well) in serum-free media for 1–6 h at 37°C or 4°C. When indicated, AlexaFluor-555 transferrin (25 μg/ml) or AlexaFluor-555 cholera toxin B subunit (10 μg/ml) were added to cells five minutes prior to the addition of vesicles. For inhibition experiments, cells were pretreated with inhibitors (methyl-β-cyclodextrin, 10 mM; methyl-α-cyclodextrin, 10 mM; sucrose, 0.45 M; chlorpromazine, 1 μg/ml; filipin, 5 μg/ml; cytochalasin D, 1 μg/ml; NiCl2, 2 mM) for 30 min, and the inhibitors remained in the media during incubation with vesicles. All subsequent steps were carried out on ice and ice-cold Dulbecco's phosphate-buffered saline (PBS) was used for washes.
Following incubation with vesicles, cells were washed twice to remove unbound vesicles. Cell exteriors were labeled in one of two ways, as indicated in figure legends: 1) Cells were incubated with AF633-conjugated wheat germ agglutinin (WGA; 25 min, on ice) and washed twice, or 2) Cells were incubated with 6-((biotinoyl)amino)hexanoic acid, succinimidyl ester (Biotin-X, SE; 10 min, on ice), washed twice, and then incubated with AF633-conjugated streptavidin (15 min, on ice) and washed twice. Cells were then fixed in 2% paraformaldehyde, mounted with ProLong AntiFade reagent, and visualized on a Nikon Eclipse TE200.
Clathrin and caveolin immunofluorescence was performed essentially as described . Following incubation with vesicles, monolayers were washed, cell exteriors were labeled with Biotin-X, SE/AF633-Streptavidin and fixed as described above. Fixed cells were washed, permeabilized (0.1% Triton X-100 in Hanks buffer; 15 min, 25°C), blocked (5% goat serum and 0.1% bovine serum albumin in permeabilization buffer; 20 min, 25°C), incubated with mouse anti-caveolin-1 or anti-clathrin antibodies (BD Biosciences; 2.5 μg/ml in permeabilization buffer; 1 h, 25°C), washed, and then labeled with AF555-conjugated goat anti-mouse secondary antibody (μg/ml in permeabilization buffer; 30 min, 25°C), and washed. Following incubation with secondary antibodies, slides were mounted and visualized as described above.
For TRAPα and tubulin immunofluorescence, fixed monolayers were permeabilized in PBS supplemented with 1 mM DTT, 1 mM PMSF, and 0.015% digitonin (to release cytoplasmic contents) for 5 min. Permeabilized cells were blocked with 1% BSA in PBS (30 min, on ice), incubated with rabbit anti-TRAPα or mouse anti-β-tubulin primary antibodies (2 μg/ml, in blocking buffer, 1 h, on ice), washed, and incubated with AF555-conjugated goat anti-mouse or anti-rabbit secondary antibodies (30 min, on ice). Following incubation with secondary antibody, slides were mounted and visualized as described above.
Leucine aminopeptidase assay
Assays were performed using the substrate Leu-p-nitroanilide (0.6 mM in 50 mM Tris-HCl, 1 mM CaCl2, pH 8.3) as described previously . Samples were preincubated with 0.5 mM dithiothreitol (30 min, 25°C) in controls experiments (data not shown) to demonstrate specificity. The production of p-nitroaniline (pNA) was monitored at 405 nm.
Detection of PaAP antibodies in sera from CF patients
Outer membranes were purified as described [46, 47]. Briefly, cells were harvested in stationary phase, resuspended (20% sucrose in 30 mM Tris, pH 8), treated with DNase I and RNaseA and broken by French Press. Membranes were separated using a sucrose gradient. Purified S470 outer membrane and vesicles (2 μg) were separated by SDS-PAGE and SYPRO Ruby protein stained or transferred to PVDF, immunoblotted using sera (1:10 dilution) from anonymous CF patients or anti-PaAP antibodies, and developed with SuperSignal (Pierce).
We thank J. R. Wright (Duke University) for P. aeruginosa strain S470, C.R.H. Raetz for strain MT616 and plasmid pJQ200SK, Erich Lanka for plasmid pMMB66EH, and M. Knowles (Adult CF Genetic Modifier Study, UNC-Chapel Hill, NC) for providing CF patient sera, Andy Ghio for providing HBE cells (EPA, NC), Chris Nicchitta (Duke Univeristy Medical Center) for TRAPα and β-tubulin antibodies, and David FitzGerald (NCI, Bethesda, MD) for monoclonal anti-PaAP antibody. We also thank J. Rudolph and T. Hsieh for equipment use, and J.L. Plank for troubleshooting. This work was supported by a Burroughs Wellcome Investigator in Pathogenesis of Infectious Disease Award (to M.J.K.), an American Lung Association research grant, the Cystic Fibrosis Foundation, the Thomas H. Davis Research Award of the ALA of NC, and the N.I.H.
- Yoon SS, Hennigan RF, Hilliard GM, Ochsner UA, Parvatiyar K, Kamani MC, Allen HL, DeKievit TR, Gardner PR, Schwab U, Rowe JJ, Iglewski BH, McDermott TR, Mason RP, Wozniak DJ, Hancock RE, Parsek MR, Noah TL, Boucher RC, Hassett DJ: Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Developmental cell. 2002, 3 (4): 593-603. 10.1016/S1534-5807(02)00295-2.PubMedView ArticleGoogle Scholar
- Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, Birrer P, Bellon G, Berger J, Weiss T, Botzenhart K, Yankaskas JR, Randell S, Boucher RC, Doring G: Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. The Journal of clinical investigation. 2002, 109 (3): 317-325.PubMed CentralPubMedView ArticleGoogle Scholar
- Wilderman PJ, Vasil AI, Johnson Z, Wilson MJ, Cunliffe HE, Lamont IL, Vasil ML: Characterization of an endoprotease (PrpL) encoded by a PvdS-regulated gene in Pseudomonas aeruginosa. Infection and immunity. 2001, 69 (9): 5385-5394. 10.1128/IAI.69.9.5385-5394.2001.PubMed CentralPubMedView ArticleGoogle Scholar
- Van Delden C, Iglewski BH: Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerging infectious diseases. 1998, 4 (4): 551-560.PubMed CentralPubMedView ArticleGoogle Scholar
- Malloy JL, Veldhuizen RA, Thibodeaux BA, O'Callaghan RJ, Wright JR: Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions. American journal of physiology. 2005, 288 (2): L409-418.PubMedGoogle Scholar
- Beveridge TJ: Structures of gram-negative cell walls and their derived membrane vesicles. Journal of bacteriology. 1999, 181 (16): 4725-4733.PubMed CentralPubMedGoogle Scholar
- McBroom A, Kuehn MJ: Chapter 2.2.4 Outer membrane vesicles. EcoSal – Escherichia coli and Salmonella: Cellular and Molecular Biology [Online]. Edited by: Curtiss R III. 2005, Washington, D.C.: ASM PressGoogle Scholar
- Bauman SJ, Kuehn MJ: Purification of outer membrane vesicles from Pseudomonas aeruginosa and their activation of an IL-8 response. Microbes Infect. 2006, 8 (9–10): 2400-2408. 10.1016/j.micinf.2006.05.001.PubMed CentralPubMedView ArticleGoogle Scholar
- Kuehn MJ, Kesty NC: Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev. 2005, 19 (22): 2645-2655. 10.1101/gad.1299905.PubMedView ArticleGoogle Scholar
- Keenan J, Day T, Neal S, Cook B, Perez-Perez G, Allardyce R, Bagshaw P: A role for the bacterial outer membrane in the pathogenesis of Helicobacter pylori infection. FEMS microbiology letters. 2000, 182 (2): 259-264. 10.1111/j.1574-6968.2000.tb08905.x.PubMedView ArticleGoogle Scholar
- Horstman AL, Kuehn MJ: Enterotoxigenic Escherichia coli secretes active heat-labile enterotoxin via outer membrane vesicles. The Journal of biological chemistry. 2000, 275 (17): 12489-12496. 10.1074/jbc.275.17.12489.PubMed CentralPubMedView ArticleGoogle Scholar
- Wai SN, Lindmark B, Soderblom T, Takade A, Westermark M, Oscarsson J, Jass J, Richter-Dahlfors A, Mizunoe Y, Uhlin BE: Vesicle-mediated export and assembly of pore-forming oligomers of the enterobacterial ClyA cytotoxin. Cell. 2003, 115 (1): 25-35. 10.1016/S0092-8674(03)00754-2.PubMedView ArticleGoogle Scholar
- Demuth DR, James D, Kowashi Y, Kato S: Interaction of Actinobacillus actinomycetemcomitans outer membrane vesicles with HL60 cells does not require leukotoxin. Cell Microbiol. 2003, 5 (2): 111-121. 10.1046/j.1462-5822.2003.00259.x.PubMedView ArticleGoogle Scholar
- Kesty NC, Mason KM, Reedy M, Miller SE, Kuehn MJ: Enterotoxigenic Escherichia coli vesicles target toxin delivery into mammalian cells. EMBO J. 2004, 23 (23): 4538-4549. 10.1038/sj.emboj.7600471.PubMed CentralPubMedView ArticleGoogle Scholar
- Balsalobre C, Silvan JM, Berglund S, Mizunoe Y, Uhlin BE, Wai SN: Release of the type I secreted alpha-haemolysin via outer membrane vesicles from Escherichia coli. Molecular microbiology. 2006, 59 (1): 99-112. 10.1111/j.1365-2958.2005.04938.x.PubMedView ArticleGoogle Scholar
- Nowotny A, Behling UH, Hammond B, Lai CH, Listgarten M, Pham PH, Sanavi F: Release of toxic microvesicles by Actinobacillus actinomycetemcomitans. Infect Immun. 1982, 37 (1): 151-154.PubMed CentralPubMedGoogle Scholar
- Kadurugamuwa JL, Beveridge TJ: Delivery of the non-membrane-permeative antibiotic gentamicin into mammalian cells by using Shigella flexneri membrane vesicles. Antimicrob Agents Chemother. 1998, 42 (6): 1476-1483.PubMed CentralPubMedGoogle Scholar
- Shoberg RJ, Thomas DD: Specific adherence of Borrelia burgdorferi extracellular vesicles to human endothelial cells in culture. Infect Immun. 1993, 61 (9): 3892-3900.PubMed CentralPubMedGoogle Scholar
- Kato S, Kowashi Y, Demuth DR: Outer membrane-like vesicles secreted by Actinobacillus actinomycetemcomitans are enriched in leukotoxin. Microbial pathogenesis. 2002, 32 (1): 1-13. 10.1006/mpat.2001.0474.PubMedView ArticleGoogle Scholar
- Kesty NC, Kuehn MJ: Incorporation of Heterologous Outer Membrane and Periplasmic Proteins into Escherichia coli Outer Membrane Vesicles. J Biol Chem. 2004, 279 (3): 2069-2076. 10.1074/jbc.M307628200.PubMed CentralPubMedView ArticleGoogle Scholar
- Heczko U, Smith VC, Mark Meloche R, Buchan AM, Finlay BB: Characteristics of Helicobacter pylori attachment to human primary antral epithelial cells. Microbes Infect. 2000, 2 (14): 1669-1676. 10.1016/S1286-4579(00)01322-8.PubMedView ArticleGoogle Scholar
- Kadurugamuwa JL, Beveridge TJ: Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion. Journal of bacteriology. 1995, 177 (14): 3998-4008.PubMed CentralPubMedGoogle Scholar
- Kadurugamuwa JL, Beveridge TJ: Natural release of virulence factors in membrane vesicles by Pseudomonas aeruginosa and the effect of aminoglycoside antibiotics on their release. J Antimicrob Chemother. 1997, 40 (5): 615-621. 10.1093/jac/40.5.615.PubMedView ArticleGoogle Scholar
- Mashburn LM, Whiteley M: Membrane vesicles traffic signals and facilitate group activities in a prokaryote. Nature. 2005, 437 (7057): 422-425. 10.1038/nature03925.PubMedView ArticleGoogle Scholar
- Alvarez-Ortega C, Harwood CS: Responses of Pseudomonas aeruginosa to low oxygen indicate that growth in the cystic fibrosis lung is by aerobic respiration. Molecular microbiology. 2007, 65 (1): 153-165. 10.1111/j.1365-2958.2007.05772.x.PubMed CentralPubMedView ArticleGoogle Scholar
- Chugani S, Greenberg EP: The influence of human respiratory epithelia on Pseudomonas aeruginosa gene expression. Microb Pathog. 2007, 42 (1): 29-35. 10.1016/j.micpath.2006.10.004.PubMed CentralPubMedView ArticleGoogle Scholar
- Corbett CR, Burtnick MN, Kooi C, Woods DE, Sokol PA: An extracellular zinc metalloprotease gene of Burkholderia cepacia. Microbiology. 2003, 149 (Pt 8): 2263-2271. 10.1099/mic.0.26243-0.PubMedView ArticleGoogle Scholar
- Rodal SK, Skretting G, Garred O, Vilhardt F, van Deurs B, Sandvig K: Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Molecular biology of the cell. 1999, 10 (4): 961-974.PubMed CentralPubMedView ArticleGoogle Scholar
- Heuser JE, Anderson RG: Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation. The Journal of cell biology. 1989, 108 (2): 389-400. 10.1083/jcb.108.2.389.PubMedView ArticleGoogle Scholar
- Yang CP, Galbiati F, Volonte D, Horwitz SB, Lisanti MP: Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells. FEBS letters. 1998, 439 (3): 368-372. 10.1016/S0014-5793(98)01354-4.PubMedView ArticleGoogle Scholar
- Campbell L, Hollins AJ, Al-Eid A, Newman GR, von Ruhland C, Gumbleton M: Caveolin-1 expression and caveolae biogenesis during cell transdifferentiation in lung alveolar epithelial primary cultures. Biochemical and biophysical research communications. 1999, 262 (3): 744-751. 10.1006/bbrc.1999.1280.PubMedView ArticleGoogle Scholar
- Lerner RS, Seiser RM, Zheng T, Lager PJ, Reedy MC, Keene JD, Nicchitta CV: Partitioning and translation of mRNAs encoding soluble proteins on membrane-bound ribosomes. RNA. 2003, 9 (9): 1123-1137. 10.1261/rna.5610403.PubMed CentralPubMedView ArticleGoogle Scholar
- Stephens SB, Dodd RD, Brewer JW, Lager PJ, Keene JD, Nicchitta CV: Stable ribosome binding to the endoplasmic reticulum enables compartment-specific regulation of mRNA translation. Molecular biology of the cell. 2005, 16 (12): 5819-5831. 10.1091/mbc.E05-07-0685.PubMed CentralPubMedView ArticleGoogle Scholar
- Tsuda K, Amano A, Umebayashi K, Inaba H, Nakagawa I, Nakanishi Y, Yoshimori T: Molecular dissection of internalization of Porphyromonas gingivalis by cells using fluorescent beads coated with bacterial membrane vesicle. Cell structure and function. 2005, 30 (2): 81-91. 10.1247/csf.30.81.PubMedView ArticleGoogle Scholar
- Grassme H, Jendrossek V, Riehle A, von Kurthy G, Berger J, Schwarz H, Weller M, Kolesnick R, Gulbins E: Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nature medicine. 2003, 9 (3): 322-330. 10.1038/nm823.PubMedView ArticleGoogle Scholar
- Kadurugamuwa JL, Beveridge TJ: Delivery of the non-membrane-permeative antibiotic gentamicin into mammalian cells by using Shigella flexneri membrane vesicles. Antimicrob Agents Chemother. 1998, 42 (6): 1476-1483.PubMed CentralPubMedGoogle Scholar
- Wagner VE, Li LL, Isabella VM, Iglewski BH: Analysis of the hierarchy of quorum-sensing regulation in Pseudomonas aeruginosa. Analytical and bioanalytical chemistry. 2007, 387 (2): 469-479. 10.1007/s00216-006-0964-6.PubMedView ArticleGoogle Scholar
- Schuster M, Lostroh CP, Ogi T, Greenberg EP: Identification, timing, and signal specificity of Pseudomonas aeruginosa quorum-controlled genes: a transcriptome analysis. Journal of bacteriology. 2003, 185 (7): 2066-2079. 10.1128/JB.185.7.2066-2079.2003.PubMed CentralPubMedView ArticleGoogle Scholar
- Nouwens AS, Beatson SA, Whitchurch CB, Walsh BJ, Schweizer HP, Mattick JS, Cordwell SJ: Proteome analysis of extracellular proteins regulated by the las and rhl quorum sensing systems in Pseudomonas aeruginosa PAO1. Microbiology (Reading, England). 2003, 149 (Pt 5): 1311-1322.View ArticleGoogle Scholar
- Schuster M, Hawkins AC, Harwood CS, Greenberg EP: The Pseudomonas aeruginosa RpoS regulon and its relationship to quorum sensing. Molecular microbiology. 2004, 51 (4): 973-985. 10.1046/j.1365-2958.2003.03886.x.PubMedView ArticleGoogle Scholar
- Engel LS, Hobden JA, Moreau JM, Callegan MC, Hill JM, O'Callaghan RJ: Pseudomonas deficient in protease IV has significantly reduced corneal virulence. Investigative ophthalmology & visual science. 1997, 38 (8): 1535-1542.Google Scholar
- Preston MJ, Seed PC, Toder DS, Iglewski BH, Ohman DE, Gustin JK, Goldberg JB, Pier GB: Contribution of proteases and LasR to the virulence of Pseudomonas aeruginosa during corneal infections. Infect Immun. 1997, 65 (8): 3086-3090.PubMed CentralPubMedGoogle Scholar
- Engel LS, Hill JM, Moreau JM, Green LC, Hobden JA, O'Callaghan RJ: Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence. Investigative ophthalmology & visual science. 1998, 39 (3): 662-665.Google Scholar
- Cahan R, Axelrad I, Safrin M, Ohman DE, Kessler E: A secreted aminopeptidase of Pseudomonas aeruginosa. Identification, primary structure, and relationship to other aminopeptidases. J Biol Chem. 2001, 276 (47): 43645-43652. 10.1074/jbc.M106950200.PubMedView ArticleGoogle Scholar
- Goldberg JB, Ohman DE: Cloning and expression in Pseudomonas aeruginosa of a gene involved in the production of alginate. Journal of bacteriology. 1984, 158 (3): 1115-1121.PubMed CentralPubMedGoogle Scholar
- Hancock RE, Nikaido H: Outer membranes of gram-negative bacteria. XIX. Isolation from Pseudomonas aeruginosa PAO1 and use in reconstitution and definition of the permeability barrier. J Bacteriol. 1978, 136 (1): 381-390.PubMed CentralPubMedGoogle Scholar
- Hancock Laboratory Methods. [http://www.cmdr.ubc.ca/bobh/methodsall.html]
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.